Skip to main content
Clinical Trials/NCT02386644
NCT02386644
Completed
Not Applicable

Premature Rupture of Membranes Assessment Via Transperineal Ultrasonography as an Alternative to Speculum Examinations

Ankara University1 site in 1 country105 target enrollmentFebruary 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preterm Premature Rupture of the Membranes
Sponsor
Ankara University
Enrollment
105
Locations
1
Primary Endpoint
True positive and negative percent agreement between transperineal assessment and PAMG-1 immunoassay as reference test.
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

This study's aim is to evaluate diagnostic accuracy of transperineal ultrasound assessment compared with speculum examination, nitrazine and placental micro globulin-1 tests.

Detailed Description

Women with early and late preterm pregnancies with a complaint of fluid leakage are enrolled in the study. Prior to speculum examination, sagittal view of the birth canal and transverse view of cervix and fornices are obtained with transperineal technique and images are stored. Then speculum examination for pooling, nitrazine test and placental microglobulin-1 tests are performed and results are recorded. Ultrasound images are analysed by an observer blind to physical examination findings. Hypoechogenic fluid appearance of adequate size around the cervix and in the fornices are considered positive. Placental microglobulin-1 test is used as reference. Sensitivity and specificity values are calculated for each test.

Registry
clinicaltrials.gov
Start Date
February 2015
End Date
April 2015
Last Updated
11 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Erkan Kalafat

Medical Doctor

Ankara University

Eligibility Criteria

Inclusion Criteria

  • Women with early and late preterm pregnancies, (i.e., women above 24th and below 37th week of gestation)
  • Pregnant women with a complaint of fluid leakage

Exclusion Criteria

  • Women with term pregnancies (i.e., women above 37th week of gestation)
  • Women with unviable pregnancies (i.e., women below 24th week of gestation)
  • Women in active labor (i.e., cervical dilatation above 4cm during admission)
  • Women with vaginal bleeding

Outcomes

Primary Outcomes

True positive and negative percent agreement between transperineal assessment and PAMG-1 immunoassay as reference test.

Time Frame: Up to 3 months

True positive rate and true negative rate of transperineal assessment will be calculated in percentages compared to PAMG-1 immunoassay as reference test.

Study Sites (1)

Loading locations...

Similar Trials